Filing Flows › Alumis (ALMS) › Recalls, complaints & regulation
Alumis (ALMS): clinical trials
Alumis (ALMS) beyond its filings: 3 active clinical trials.
Alumis' latest quarter
Alumis, Q2 2026: revenue $1.7M (-38% year over year), net loss $142M, operating cash flow −$81.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Alumis have?
3 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.